Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,690 | -3,700 | -2,000 | -11,060 | N/A |
| Depreciation Amortization | 1,110 | 720 | 320 | N/A | N/A |
| Other Working Capital | 1,160 | 460 | 370 | N/A | N/A |
| Other Operating Activity | -670 | -620 | -20 | 3,430 | 0 |
| Operating Cash Flow | $-4,090 | $-3,140 | $-1,330 | $-7,630 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,160 | -9,660 | -2,750 | N/A | N/A |
| Other Investing Activity | -100 | -250 | -320 | -35,650 | 0 |
| Investing Cash Flow | $-11,260 | $-9,910 | $-3,070 | $-35,650 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -450 | -300 | -150 | N/A | N/A |
| Other Financing Activity | 16,700 | 12,440 | 4,280 | 45,960 | 0 |
| Financing Cash Flow | $16,250 | $12,140 | $4,130 | $45,960 | $N/A |
| Beginning Cash Position | 4,480 | 4,480 | 4,480 | 1,800 | N/A |
| End Cash Position | 5,380 | 3,570 | 4,200 | 4,480 | N/A |
| Net Cash Flow | $900 | $-910 | $-280 | $2,670 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,090 | -3,140 | -1,330 | -7,630 | N/A |
| Free Cash Flow | -4,090 | -3,140 | -1,330 | -7,630 | 0 |